Pub Date : 2013-06-01DOI: 10.1192/PB.BP.111.035915
N. Painuly, Ritu Painuly, R. Heun, P. Sharan
Sciences Citation Index (SSCI), King’s Fund, DH-Data, CINAHL, Allied and Complementary Medicine Database (AMED) and British Nursing Index (BNI). Combinations of the terms ‘SSRI’, ‘selective serotonin reuptake inhibitor(s)’, ‘SRI’, ‘serotonin reuptake inhibitors’, ‘paroxetine’, ‘pregnancy’, ‘congenital malformation(s)’, ‘congenital defect(s)’, ‘cardiovascular malformation(s)’, ‘cardiac defect(s)’, ‘cardiovascular defect(s)’, ‘fetal malformation(s)’ and ‘fetal anomalies’ were used for the search. The search was restricted to articles published in English but there was no exclusion on the basis of country, ethical approval, etc. No grey literature was searched for this review. Each abstract/title and article was scrutinised by two of the authors (N.P. and R.P.) and the differences between them were resolved by consensus. Relevant articles were hand-searched for cross-references. The GlaxoSmithKline website was searched for recent data on paroxetine. To exclude repetitive data-sets, only the study with the most updated data was taken up for analysis. A repeat data search was done in August 2012, after the first review of this article, and results were updated.
{"title":"Risk of cardiovascular malformations after exposure to paroxetine in pregnancy: meta-analysis","authors":"N. Painuly, Ritu Painuly, R. Heun, P. Sharan","doi":"10.1192/PB.BP.111.035915","DOIUrl":"https://doi.org/10.1192/PB.BP.111.035915","url":null,"abstract":"Sciences Citation Index (SSCI), King’s Fund, DH-Data, CINAHL, Allied and Complementary Medicine Database (AMED) and British Nursing Index (BNI). Combinations of the terms ‘SSRI’, ‘selective serotonin reuptake inhibitor(s)’, ‘SRI’, ‘serotonin reuptake inhibitors’, ‘paroxetine’, ‘pregnancy’, ‘congenital malformation(s)’, ‘congenital defect(s)’, ‘cardiovascular malformation(s)’, ‘cardiac defect(s)’, ‘cardiovascular defect(s)’, ‘fetal malformation(s)’ and ‘fetal anomalies’ were used for the search. The search was restricted to articles published in English but there was no exclusion on the basis of country, ethical approval, etc. No grey literature was searched for this review. Each abstract/title and article was scrutinised by two of the authors (N.P. and R.P.) and the differences between them were resolved by consensus. Relevant articles were hand-searched for cross-references. The GlaxoSmithKline website was searched for recent data on paroxetine. To exclude repetitive data-sets, only the study with the most updated data was taken up for analysis. A repeat data search was done in August 2012, after the first review of this article, and results were updated.","PeriodicalId":89639,"journal":{"name":"The psychiatrist","volume":"42 1","pages":"198-203"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88869288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-06-01DOI: 10.1192/PB.BP.112.042234
Lawrence Martean
Schema Therapy in Practice: An Introductory Guide to the Schema Mode Approach By Arnoud Arntz, Gitta Jacob Wiley-Blackwell, 2013, £32.99, pb, 276 pp. ISBN: 9781119962861 The continued proliferation of ‘branded’ psychotherapies can induce cynical beliefs that these are simply products of old
图式疗法的实践:图式模式方法的导论作者:Arnoud Arntz, Gitta Jacob willey - blackwell, 2013，£32.99,pb, 276 pp. ISBN: 9781119962861“品牌”心理疗法的持续扩散可能会引发愤世嫉俗的信念，认为这些只是旧的产品
{"title":"Schema Therapy in Practice: An Introductory Guide to the Schema Mode Approach By Arnoud Arntz, Gitta Jacob, Wiley-Blackwell, 2013, £32.99, pb, 276 pp. ISBN: 9781119962861","authors":"Lawrence Martean","doi":"10.1192/PB.BP.112.042234","DOIUrl":"https://doi.org/10.1192/PB.BP.112.042234","url":null,"abstract":"Schema Therapy in Practice: An Introductory Guide to the Schema Mode Approach By Arnoud Arntz, Gitta Jacob Wiley-Blackwell, 2013, £32.99, pb, 276 pp. ISBN: 9781119962861 \u0000\u0000The continued proliferation of ‘branded’ psychotherapies can induce cynical beliefs that these are simply products of old","PeriodicalId":89639,"journal":{"name":"The psychiatrist","volume":"13 1","pages":"216-216"},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85226052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-05-01DOI: 10.1192/PB.BP.112.040543
M. Skelton, S. Thacker, A. Forbes-Haley, Mahendra Kumar, E. Holliday
Aims and method A completed audit cycle, consisting of email surveys of all psychiatrists and a review of acute trust information technology registers was undertaken in Derbyshire Healthcare NHS Foundation Trust, to assess whether psychiatrists could access electronic laboratory results from the neighbouring acute trust laboratory. This was replicated in Nottinghamshire Healthcare NHS Trust, with an initial audit; plans were then implemented to increase access. Results In Derbyshire, 14% of psychiatrists could access electronic results initially, with limited ward access. By re-audit, all wards had access, and 28% used those systems. The later initial audit in Nottinghamshire Healthcare Trust revealed 6% access. Clinical implications Benefits of electronic results include clinical (faster decisions, safer monitoring, prompt detection of acute problems); efficiency savings (less wasted time telephoning); and other (improved relationships with general practitioners and laboratories, reduced marginalisation of patients with mental illness and professionals). There may be considerable clinical and efficiency savings for trusts.
{"title":"Psychiatrists' access to electronic laboratory results","authors":"M. Skelton, S. Thacker, A. Forbes-Haley, Mahendra Kumar, E. Holliday","doi":"10.1192/PB.BP.112.040543","DOIUrl":"https://doi.org/10.1192/PB.BP.112.040543","url":null,"abstract":"Aims and method A completed audit cycle, consisting of email surveys of all psychiatrists and a review of acute trust information technology registers was undertaken in Derbyshire Healthcare NHS Foundation Trust, to assess whether psychiatrists could access electronic laboratory results from the neighbouring acute trust laboratory. This was replicated in Nottinghamshire Healthcare NHS Trust, with an initial audit; plans were then implemented to increase access. Results In Derbyshire, 14% of psychiatrists could access electronic results initially, with limited ward access. By re-audit, all wards had access, and 28% used those systems. The later initial audit in Nottinghamshire Healthcare Trust revealed 6% access. Clinical implications Benefits of electronic results include clinical (faster decisions, safer monitoring, prompt detection of acute problems); efficiency savings (less wasted time telephoning); and other (improved relationships with general practitioners and laboratories, reduced marginalisation of patients with mental illness and professionals). There may be considerable clinical and efficiency savings for trusts.","PeriodicalId":89639,"journal":{"name":"The psychiatrist","volume":"34 1","pages":"160-163"},"PeriodicalIF":0.0,"publicationDate":"2013-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73769373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-05-01DOI: 10.1192/pb.bp.112.042275
S. Kohli
The Psychedelic Renaissance: Reassessing the Role of Psychedelic Drugs in 21st Century Psychiatry and Society Ben Sessa Muswell Hill Press, 2012, £16.95, pb, 240 pp. ISBN: 9781908995001 Throughout the period of training and in clinical practice, there is a tendency to develop a prejudiced view
{"title":"The Psychedelic Renaissance: Reassessing the Role of Psychedelic Drugs in 21st Century Psychiatry and Society","authors":"S. Kohli","doi":"10.1192/pb.bp.112.042275","DOIUrl":"https://doi.org/10.1192/pb.bp.112.042275","url":null,"abstract":"The Psychedelic Renaissance: Reassessing the Role of Psychedelic Drugs in 21st Century Psychiatry and Society Ben Sessa Muswell Hill Press, 2012, £16.95, pb, 240 pp. ISBN: 9781908995001 \u0000\u0000Throughout the period of training and in clinical practice, there is a tendency to develop a prejudiced view","PeriodicalId":89639,"journal":{"name":"The psychiatrist","volume":"39 1","pages":"184-184"},"PeriodicalIF":0.0,"publicationDate":"2013-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73833415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-05-01DOI: 10.1192/PB.BP.113.042739
Abraham M. Nussbaum, T. Stroup
Aims and method To review the evidence for the use of paliperidone palmitate for people with schizophrenia and schizophrenia-like illnesses. We searched the Cochrane Schizophrenia Group Specialised Register and contacted the manufacturer of paliperidone palmitate, the US Food and Drug Administration, and the authors of papers that reported study results. Results Based on the evidence from five short-term, placebo-controlled studies, paliperidone palmitate is efficacious as an antipsychotic. Its adverse effects are similar to those of the closely related compounds paliperidone and risperidone. Extrapyramidal side-effects, weight gain and tachycardia are more common with paliperidone palmitate than placebo. Paliperidone palmitate was associated with substantial increases in serum prolactin but not with increased sexual side-effects in these studies. In two studies paliperidone palmitate was similar to depot risperidone. Clinical implications Paliperidone palmitate is an effective antipsychotic whose optimal dose appears to be between 39 and 234 mg every 4 weeks. We have no data assessing its long-term effectiveness or comparing it with any long-acting injected antipsychotic other than depot risperidone.
{"title":"Drug information update: paliperidone palmitate for schizophrenia","authors":"Abraham M. Nussbaum, T. Stroup","doi":"10.1192/PB.BP.113.042739","DOIUrl":"https://doi.org/10.1192/PB.BP.113.042739","url":null,"abstract":"Aims and method To review the evidence for the use of paliperidone palmitate for people with schizophrenia and schizophrenia-like illnesses. We searched the Cochrane Schizophrenia Group Specialised Register and contacted the manufacturer of paliperidone palmitate, the US Food and Drug Administration, and the authors of papers that reported study results. Results Based on the evidence from five short-term, placebo-controlled studies, paliperidone palmitate is efficacious as an antipsychotic. Its adverse effects are similar to those of the closely related compounds paliperidone and risperidone. Extrapyramidal side-effects, weight gain and tachycardia are more common with paliperidone palmitate than placebo. Paliperidone palmitate was associated with substantial increases in serum prolactin but not with increased sexual side-effects in these studies. In two studies paliperidone palmitate was similar to depot risperidone. Clinical implications Paliperidone palmitate is an effective antipsychotic whose optimal dose appears to be between 39 and 234 mg every 4 weeks. We have no data assessing its long-term effectiveness or comparing it with any long-acting injected antipsychotic other than depot risperidone.","PeriodicalId":89639,"journal":{"name":"The psychiatrist","volume":"1 1","pages":"164-166"},"PeriodicalIF":0.0,"publicationDate":"2013-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89604107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-05-01DOI: 10.1192/PB.BP.112.038414
R. Yadav, A. Zigmond
Aims and method To understand circumstances in which urgent treatment provisions are used in clinical practice, by means of a retrospective study. A list of patients to whom Sections 62, 64B and 64G of the Mental Health Act 1983 were applied during the 1-year study period was obtained from the information technology department. Case notes were traced for detailed information on the circumstances of use of these provisions. Results The most common reason for urgent treatment was to continue the established treatment plan rather than to start a new treatment (45% Section 62, 84% Section 64). The urgent treatment provisions were most commonly used because of a delay in examination by a second opinion appointed doctor in 45% cases for Section 62 and 84% cases for Sections 64B and 64G. Clinical implications This is probably unlawful use of the urgent treatment provisions.
{"title":"Mental Health Act 1983: use of urgent treatment in clinical practice","authors":"R. Yadav, A. Zigmond","doi":"10.1192/PB.BP.112.038414","DOIUrl":"https://doi.org/10.1192/PB.BP.112.038414","url":null,"abstract":"Aims and method To understand circumstances in which urgent treatment provisions are used in clinical practice, by means of a retrospective study. A list of patients to whom Sections 62, 64B and 64G of the Mental Health Act 1983 were applied during the 1-year study period was obtained from the information technology department. Case notes were traced for detailed information on the circumstances of use of these provisions.\u0000\u0000Results The most common reason for urgent treatment was to continue the established treatment plan rather than to start a new treatment (45% Section 62, 84% Section 64). The urgent treatment provisions were most commonly used because of a delay in examination by a second opinion appointed doctor in 45% cases for Section 62 and 84% cases for Sections 64B and 64G.\u0000\u0000Clinical implications This is probably unlawful use of the urgent treatment provisions.","PeriodicalId":89639,"journal":{"name":"The psychiatrist","volume":"388 1","pages":"156-159"},"PeriodicalIF":0.0,"publicationDate":"2013-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80814508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-05-01DOI: 10.1192/PB.BP.112.040998
N. Aggarwal
In July 2012, the American Psychiatric Association (APA) closed its final commenting period on draft criteria for the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), slated for publication in May 2013. DSM-5 raises familiar questions about the cultural assumptions of proposed diagnoses, the scientific evidence base of these criteria and their validity in international settings. I review these issues since the publication of DSM-IV. I assess the cultural validity of DSM-5 and suggest areas of improvement.
{"title":"From DSM-IV to DSM-5: an interim report from a cultural psychiatry perspective","authors":"N. Aggarwal","doi":"10.1192/PB.BP.112.040998","DOIUrl":"https://doi.org/10.1192/PB.BP.112.040998","url":null,"abstract":"In July 2012, the American Psychiatric Association (APA) closed its final commenting period on draft criteria for the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), slated for publication in May 2013. DSM-5 raises familiar questions about the cultural assumptions of proposed diagnoses, the scientific evidence base of these criteria and their validity in international settings. I review these issues since the publication of DSM-IV. I assess the cultural validity of DSM-5 and suggest areas of improvement.","PeriodicalId":89639,"journal":{"name":"The psychiatrist","volume":"20 1","pages":"171-174"},"PeriodicalIF":0.0,"publicationDate":"2013-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73242660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-05-01DOI: 10.1192/PB.BP.112.041426
Stephen Ginn
Psychology in the Bathroom By Nick Haslam Palgrave Macmillan, 2012, £50.00, hb, 184 pp. ISBN: 9780230368248 With its centrality to psychoanalytic thought, excretion was once essential to the understanding of human motivation and personality. No longer, writes Professor Nick Haslam, author of
{"title":"Psychology in the Bathroom","authors":"Stephen Ginn","doi":"10.1192/PB.BP.112.041426","DOIUrl":"https://doi.org/10.1192/PB.BP.112.041426","url":null,"abstract":"Psychology in the Bathroom By Nick Haslam Palgrave Macmillan, 2012, £50.00, hb, 184 pp. ISBN: 9780230368248 \u0000\u0000With its centrality to psychoanalytic thought, excretion was once essential to the understanding of human motivation and personality. No longer, writes Professor Nick Haslam, author of","PeriodicalId":89639,"journal":{"name":"The psychiatrist","volume":"161 1","pages":"184-184"},"PeriodicalIF":0.0,"publicationDate":"2013-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77846598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-05-01DOI: 10.1192/PB.BP.112.040840
H. Cowie
Aims and method The upsurge of cyberbullying is a frequent cause of emotional disturbance in children and young people. The situation is complicated by the fact that these interpersonal safety issues are actually generated by the peer group and in contexts that are difficult for adults to control. This article examines the effectiveness of common responses to cyberbullying. Results Whatever the value of technological tools for tackling cyberbullying, we cannot avoid the fact that this is an interpersonal problem grounded in a social context. Clinical implications Practitioners should build on existing knowledge about preventing and reducing face-to-face bullying while taking account of the distinctive nature of cyberbullying. Furthermore, it is essential to take account of the values that young people are learning in society and at school.
{"title":"Cyberbullying and its impact on young people’s emotional health and well-being","authors":"H. Cowie","doi":"10.1192/PB.BP.112.040840","DOIUrl":"https://doi.org/10.1192/PB.BP.112.040840","url":null,"abstract":"Aims and method The upsurge of cyberbullying is a frequent cause of emotional disturbance in children and young people. The situation is complicated by the fact that these interpersonal safety issues are actually generated by the peer group and in contexts that are difficult for adults to control. This article examines the effectiveness of common responses to cyberbullying. Results Whatever the value of technological tools for tackling cyberbullying, we cannot avoid the fact that this is an interpersonal problem grounded in a social context. Clinical implications Practitioners should build on existing knowledge about preventing and reducing face-to-face bullying while taking account of the distinctive nature of cyberbullying. Furthermore, it is essential to take account of the values that young people are learning in society and at school.","PeriodicalId":89639,"journal":{"name":"The psychiatrist","volume":"37 1","pages":"167-170"},"PeriodicalIF":0.0,"publicationDate":"2013-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87261651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The recent letter by Das[1][1] was a succinct and clear appraisal of much of the Schizophrenia Commission’s report. Das takes issue with the report’s point that ‘shared decision making on medication choices is essential’, commenting that this cannot refer to ‘the patient with chronic
{"title":"Commissions, coercion and choice","authors":"R. McCutcheon","doi":"10.1192/pb.37.5.179","DOIUrl":"https://doi.org/10.1192/pb.37.5.179","url":null,"abstract":"The recent letter by Das[1][1] was a succinct and clear appraisal of much of the Schizophrenia Commission’s report. Das takes issue with the report’s point that ‘shared decision making on medication choices is essential’, commenting that this cannot refer to ‘the patient with chronic","PeriodicalId":89639,"journal":{"name":"The psychiatrist","volume":"68 1","pages":"179-179"},"PeriodicalIF":0.0,"publicationDate":"2013-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76523084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：